Literature DB >> 16932628

Coronary artery disease in patients with systemic lupus erythematosus.

Michael Galindo1, Lorinda Chung, Seth D Crockett, Eliza F Chakravarty.   

Abstract

BACKGROUND: A 24-year-old woman with an 11-year history of systemic lupus erythematosus presented with exacerbation of chronic abdominal pain followed by substernal chest pain. She had a history of pericarditis secondary to systemic lupus erythematosus and of varicella-zoster reactivation secondary to immunosuppression. Long-term medications included prednisolone, hydroxychloroquine, aspirin, and mycophenolate mofetil. INVESTIGATIONS: Physical examination, mesenteric angiography, CT of the abdomen, esophagogastroduodenoscopy, colonoscopy, pelvic ultrasound, laboratory testing, serologic testing, cardiac echocardiography, electrocardiography and coronary angiography. DIAGNOSIS: Acute myocardial infarction secondary to severe multivessel atherosclerotic coronary artery disease. MANAGEMENT: Intra-aortic balloon pump followed by emergent four-vessel coronary artery bypass grafting. Aspirin, hydroxychloroquine, and mycophenolate mofetil were continued and a judicious tapering of prednisolone was initiated.

Entities:  

Mesh:

Year:  2005        PMID: 16932628     DOI: 10.1038/ncprheum0037

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN: 1745-8382


  2 in total

1.  Quantitative assessment of left ventricular systolic function in patients with systemic lupus erythematosus: a non-invasive pressure-strain loop technique.

Authors:  Xia Li; Huijuan Chen; Meng Han; Yanling Luo; Fengzhen Liu; Lili Chen; Xiaolin Wang; Yu Zhao; Ruirui Kang; Chujun Wang; Chunquan Zhang
Journal:  Quant Imaging Med Surg       Date:  2022-06

Review 2.  Inflammation and Coronary Microvascular Dysfunction in Autoimmune Rheumatic Diseases.

Authors:  Elisabetta Zanatta; Claudia Colombo; Gianpiero D'Amico; Thomas d'Humières; Carlo Dal Lin; Francesco Tona
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.